Cellnovo Launches Mobile-Enabled Insulin Pump System in UK
Cellnovo recently launched its mobile-enabled insulin pump system in the UK, after receiving very positive feedback from a usability study that began in the UK in October of 2013. The company plans to make the system available in the Netherlands and France over the first half of 2014, which will be the first stage in a larger European roll-out campaign. Cellnovo previously announced that it planned to file its insulin pump system for approval in the US in 2014, but the company has not made any recent announcements concerning plans for the US.
As background, the new pump system is designed with the mobile experience in mind. It combines a small patch pump, a short infusion set, and a mobile touchscreen controller. Like the OmniPod, patients will remotely operate the insulin pump from the controller, which also serves as a blood glucose monitor. The controller connects to the web, uploads data in near real-time, and allows users the option to input information regarding their exercise and carbohydrate intake. The online data management system associated with the pump allows users to see their blood glucose levels, insulin use, activity and diet information. Notably, healthcare professionals will also be able to see real-time information. For more information on the Cellnovo insulin pump system and for the most current updates regarding approval and release in other areas, please see the company website. –AF/AB
